Chamla Dick, Luo Chewe, Adjorlolo-Johnson Georgette, Vandelaer Jos, Young Mark, Costales Maria Otelia, McClure Craig
Paediatric HIV, Health Section.
Paediatr Int Child Health. 2015;35(4):298-304. doi: 10.1080/20469047.2015.1109233. Epub 2014 Dec 26.
Integration of HIV infant testing into immunization sessions is one of the strategies designed to increase coverage of early infant diagnosis.
To determine the evidence on the outcomes of such integration.
A systematic review of peer-reviewed and grey literature was undertaken from electronic sources such as MEDLINE, Google Scholar, websites of international agencies, past conferences and ministries of health reports published between year 2002 and 2013. Randomized controlled trials, observational and qualitative studies were searched and those meeting selection criteria were selected and relevant information extracted using structured tool. Statistical pooling was not possible owing to the heterogeneity of the study designs and outcome measures.
Of the nine articles which met the selection criteria, none used a randomized controlled design. Of these, five articles measured mother's acceptability of their infants being tested for HIV during its first pentavalent or DPT vaccination visit, and 89·5-100% accepted. Four articles reported the proportion of mothers who returned for HIV test results, ranging from 56·8% to 86·0%. Increased uptake of HIV testing following integration was confirmed by two articles. Only one study in Tanzania determined the uptake of vaccinations following integration, with urban facilities showing stable or slight increase of monthly vaccine uptake while decreases were observed across the rural sites. In two articles, stigma was perceived by service-providers and mothers as the potential risk following integration, particularly in rural settings.
Despite the limited number of articles, the findings in this systematic review suggest that HIV testing during immunization clinic visits is acceptable and feasible as a possible model for service delivery. However, the impact on vaccination uptake needs further study.
将艾滋病毒婴儿检测纳入免疫接种环节是旨在提高早期婴儿诊断覆盖率的策略之一。
确定这种整合的结果方面的证据。
从电子资源,如MEDLINE、谷歌学术、国际机构网站、过往会议以及2002年至2013年期间发布的卫生部报告等,对同行评审文献和灰色文献进行系统综述。检索随机对照试验、观察性研究和定性研究,选择符合入选标准的研究,并使用结构化工具提取相关信息。由于研究设计和结局指标的异质性,无法进行统计合并。
在符合入选标准的9篇文章中,没有一篇采用随机对照设计。其中,5篇文章衡量了母亲对其婴儿在首次五价疫苗或百白破疫苗接种就诊时进行艾滋病毒检测的接受度,接受度为89.5%至100%。4篇文章报告了返回获取艾滋病毒检测结果的母亲比例,范围为56.8%至86.0%。两篇文章证实整合后艾滋病毒检测的接受度有所提高。坦桑尼亚只有一项研究确定了整合后疫苗接种的接受情况,城市设施的月度疫苗接种量显示稳定或略有增加,而农村地区则出现下降。在两篇文章中,服务提供者和母亲认为整合后潜在的风险是耻辱感,尤其是在农村地区。
尽管文章数量有限,但本系统综述的结果表明,在免疫接种门诊就诊时进行艾滋病毒检测作为一种可能的服务提供模式是可接受且可行的。然而,对疫苗接种接受度的影响需要进一步研究。